Optimize your Market Access strategies and fund your growth
HealthTech180 is a one-stop Consulting and Financial Advisory boutique specialized in Healthcare (Pharma, Biotech, Medical Device, Diagnostics, Digital Health and Cosmetics).
We are a group of experienced executives, consultants, doctors, investors and financial advisors who bring a diverse and deep experience to every healthcare engagement.
We are Market Access specialists that will take your business to the next level by finding the right investors, distribution partners or by negotiating the best licensing deals. We pride ourselves on providing the best service to all our clients – helping them every step of the way.
The members of our Team always take a hands-on approach with integrity, trust and commitment.
Services : your needs are our priorities
With a strong track record in Funding and M&A, we are your one-stop shop for your growth needs. We offer Funding, Market Access, Distribution and Licensing services. We will define the best market access strategy while ensuring it is implemented with the most trustworthy partners.
72% of PE and VC investors find it difficult to Access high-quality cross border targets in the healthcare sector.
For 94% of PE and VC investors, aggressive value creation is key in the healthcare sector.
Our services are 100% covered by our experienced and renowned experts. Check our Team´s profiles!
HealthTech180 is 180% committed to the success of our clients!
Daily updates from the HealthTech sector, and about HT180 and our advisors: Buy-Outs, Licensing, Funding Rounds, Regulatory etc. Important news not to be missed! Follow us on Linkedin and Twitter.
Elsevier, a global information analytics business specializing in science and health, and part of RELX, has acquired 3D4Medical, the global anatomy education company headquartered in Dublin,
TauRx : Minimum Dose of Hydromethylthionine Could Slow Cognitive Decline and Brain Atrophy in Mild-to-moderate Alzheimer’s Disease
TauRx has reportedunexpected results of a pharmacokinetic analysis of the relationship between treatment dose, blood levels and pharmacological activity of the drug hydromethylthionine on the